glp-1 agonists muscle loss and Loss: Semaglutide, Tirzepatide & Lean Mass Study finds GLP-1 receptor agonists

[DOI] [PubMed] [Google Scholar] 94.Robinson LE, Holt TA, Rees K, Randeva HS, O'Hare JP

Ongoing and planned trials (Supplementary Table 3

The formulation has recently changed, so there is a risk of medication error notably in the transition period when both formulations are available

S.WeirV

Adipose tissue is divided into WAT with a small number of mitochondria in the cell and BAT with a large number of mitochondria in the cell

Heerspink HJL, Parving HH, Andress DL et al (2019) Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial